Search

Search Constraints

You searched for: Author/Creator Byrtek, Michelle

Search Results

1. [18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice. Issue 4 (3rd April 2017)

2. Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States. Issue 5 (May 2015)

3. Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma‐related mortality in elderly follicular lymphoma in the United States. (7th April 2015)

4. Evaluation of the effect of prospective biomarker testing on progression-free survival in diffuse large B-cell lymphoma. Issue 4 (21st March 2021)

5. Outcomes following watchful waiting for stage II–IV follicular lymphoma patients in the modern era. (5th January 2016)

6. Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: Results of the National LymphoCare Study. Issue 23 (4th September 2013)

7. Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: Results of the National LymphoCare Study. Issue 23 (4th September 2013)

8. The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States. Issue 12 (25th March 2014)

9. The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States. Issue 12 (25th March 2014)